Law360, New York (December 17, 2008) -- Lupin Ltd. has become the latest company to settle patent litigation with Schering Corp. over a planned generic version of the allergy medication Clarinex.
Lupin and Schering both said Wednesday that under the settlement, Lupin will license the Clarinex patents from Schering and will be able to launch its generic version on July 1,...


